Abstract
Background: Enhanced External Counterpulsation (EECP) non-invasively improves quality of life and functional capacity in ischemic cardiomyopathy patients (pts). Whether completion of a 30hour course of EECP has durable benefits in decreasing heart failure (HF) decompensation and MACE in ischemic HF pts is unknown. Methods: The IEPR2 is a prospective, sequential registry of 3,000 EECP treated pts. EECP dropouts, when immediate treatment events are excluded, provide a comparator group of durable effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
